Variable | CKD (n = 42) | No CKD (n = 360) | p value | Overall |
Type of HIV | ||||
HIV-1 | 88.1% (37) | 95.3% (343) | 0.0528 | 85.8% (380) |
Dual HIV | 0% (0) | 0.8% (3) | 0.5526 | 12.9% (19) |
HIV- 2 | 11.9% (5) | 3.9% (14) | 0.0205 | 1.4% (3) |
Duration of the infection | ||||
Less than 2 years | 0% (0) | 0.7% (3) | 1 | 0.7 (3) |
2 - 5 years | 12.2% (5) | 21.3% (77) | 0.1599 | 20.4% (82) |
More than 5 years | 87.8% (37) | 78% (280) | 0.1353 | 78.9% (317) |
Opportunist infections | ||||
Herpes Zoster virus infection | 19% (8) | 30% (108) | 0.1382 | 28.9% (116) |
Toxoplasmosis | 2.4% (1) | 1.4% (5) | 0.6158 | 1.5% (6) |
CMV infection | 2.4% (1) | 0.3% (1) | 0.0668 | 0.5% (2) |
Candidiasis | 4.8% (2) | 3.3% (12) | 0.6327 | 3.5% (14) |
Pneumonia | 0% (0) | 0.6% (2) | 0.6282 | 0.5% (2) |
Herpes virus infection | 0% (0) | 2.8% (10) | 0.274 | 2.5% (10) |
Tuberculosis | 7.1% (3) | 8.6% (31) | 0.7462 | 8.4% (34) |
CDC Stage | ||||
Category A | 11.9% (5) | 16.4% (59) | 0.4523 | 15.9% (64) |
Category B | 64.3% (27) | 65.8% (237) | 0.8416 | 65.7% (264) |
Category C | 23.8% (10) | 17.8% (64) | 0.3398 | 18.4% (74) |
Body mass index | ||||
Underweight | 19% (8) | 21.9% (79) | 0.6662 | 21.6% (87) |
Normal | 73.8% (31) | 55.3% (199) | 0.0216 | 57.2% (230) |
Overweight | 2.4% (1) | 8.3% (30) | 0.1712 | 7.7% (31) |
Obesity | 4.8% (2) | 14.4% (52) | 0.0816 | 13.4% (54) |
High blood pressure | ||||
Yes | 19% (8) | 20.6% (74) | 0.8185 | 20.4% (82) |
No | 81% (34) | 79.4% (286) |
| 79.6% (320) |